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Scope: Iron is an essential nutrient.However, in animalmodels, excess unabsorbed dietary iron
residing within the colonic lumen has been shown to exacerbate inflammatory bowel disease
and intestinal cancer. Therefore, the aims of this study were to screen a panel of alginates to
identify a therapeutic that can chelate this pool of iron and thus be beneficial for intestinal
health.
Methods and results: Using several in vitro intestinal models, it is evident that only one
alginate (Manucol LD) of the panel tested was able to inhibit intracellular iron accumulation as
assessed by iron-mediated ferritin induction, transferrin receptor expression, intracellular 59Fe
concentrations, and iron flux across a Caco-2 monolayer. Additionally, Manucol LD suppressed
iron absorption in mice, which was associated with increased fecal iron levels indicating iron
chelation within the gastrointestinal tract. Furthermore, the bioactivity of Manucol LD was
found to be highly dependent on both its molecular weight and its unique compositional
sequence.
Conclusion: Manucol LD could be useful for the chelation of this detrimental pool of unab-
sorbed iron and it could be fortified in foods to enhance intestinal health.
Keywords:
Absorption / Alginate / Chelation / Intestinal / Iron
 Additional supporting information may be found in the online version of this article atthe publisher’s web-site
1 Introduction
Iron is an essential nutrient with many cellular functions
reliant upon iron-catalyzed processes such as DNA synthesis
and ATP generation [1, 2]. Total body iron levels in adult
males are between 3000 and 4000 mg, with a daily nutri-
tional need for iron of 20 mg that is mostly required for
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Abbreviations: ADPs, alginate degrade products; AlgE1, algi-
nate epimerase 1;AUC, analytical ultracentrifugation; CD, circular
dichroism; DGA, D-glucuronic acid; EpLD, epimerized Manucol
LD; FCS, fetal calf serum; G, guluronic acid;M, mannuronic acid;
TfR1, transferrin receptor 1
erythropoiesis [3]. This daily requirement of iron is ingested
from the diet; however, it is known that only 0.7–22.9%
of ingested nonheme iron is absorbed within the small
bowel [4]. As a consequence, the remaining dietary iron
resides within the large bowel for hours to days. Recent
reports have concluded that this “luminal iron” (iron present
within the lumen of the colon) has a detrimental effect on
intestinal health [5, 6]. Most notably, two recent murine
studies have shown that removal of dietary iron frommodels
of inflammatory bowel disease and intestinal cancer resulted
in a suppression of disease phenotype, while consumption of
excess dietary iron exacerbated the conditions [5,6]. How this
excess iron is mediating these effects is unknown; however,
it could be via oncogenic signaling (the Wnt signaling path-
way) [7], the generation of reactive oxygen species [8–10], or
through the modulation of the intestinal microbiome [6, 11].
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Iron chelation represents a platform for therapeutic in-
tervention, whereby ligated iron would be neutralized and
unable to partake in any toxicity-related processes; this has
indeed been demonstrated in the context of chelation of ex-
cess systemic iron, where the use of iron chelators has been
shown to have beneficial effects [12]. However, with respect to
luminal iron a therapeutic agent must not demonstrate sys-
temic iron binding and iron chelation must solely take place
within the gastrointestinal tract. As such, a compound that
demonstrates iron-binding potential while having a limited
bioavailability needs to be identified. Sodium alginates are a
fiber found throughout many foods that demonstrate these
physicochemical properties [13, 14].
Alginates sourced from algae are formed of unbranched,
1–4 linked -D-mannuronic acid (M) and -L-guluronic acid
(G). The arrangement of G and M residues along the poly-
meric backbone sequence is ordered being heteropolymeric
(e.g., GMGMGM) or homopolymeric (e.g., MMMGGG) [15].
The physical properties of alginate can differ depending on
their molecular weight and GM sequence; these structural
differences give rise to a plethora of possible structural com-
positions. How these compositional differences may alter the
biochemical actions of alginates is unknown, and in partic-
ular how they influence iron binding in vitro and in vivo is
not known. As such, the impact of a range of alginates (rep-
resenting different chemical compositions) on in vitro and in
vivo cellular iron metabolism was assessed. Further to this,
the physicochemical properties of alginate that are crucial for
its effects on cellular iron metabolism were examined to re-
veal the alginate chemical composition required for luminal
iron chelation. Results from these experiments identify an
alginate that is nutritionally beneficial and likely to be useful
in enhancing intestinal health.
2 Materials and methods
2.1 Cell culture
RKO cells were grown in a growth medium that consisted of
DMEM supplemented with fetal calf serum (FCS, 10 % v/v),
penicillin (100 U/mL) and streptomycin (0.1 mg/mL). Caco-
2 cells were grown using a similar growth medium that was
supplemented with nonessential amino acids 1% v/v. Both
cell lines were purchased from the American Type Culture
Collection (ATCC).
In experiments with iron co-incubation, a standard pro-
tocol was employed as previously described [13]. Through-
out all experiments, the form of iron used was FeSO4.
To create alginate stimulation media, alginate (2% w/v in
DI H2O) was mixed with growth medium with or with-
out iron (FeSO4 · 7H2O, 100 M) to create a resultant
0.3% alginate medium, with or without iron supplemen-
tation. These stimulation media were cultured with cells
for 24 h. After this time period, media were removed and
cells were washed with PBS and lysed in RIPA lysis buffer
(1% 4-nonylphenyl poly(ethylene glycol), 0.5% sodium deoxy-
cholate, 0.1% sodium dodecyl sulfate (w/v) in DI H2O).
2.2 Caco-2 monolayer
Caco-2 cells were seeded into pretreated collagen-coated 6-
well Transwell inserts at a concentration of 4 × 105 cells/mL.
Cells were grown for 20 days post confluency. Prior to cul-
ture with iron and/or alginate, cell medium was changed
to FCS-free Minimum Essential Medium as previously re-
ported [16]. Subsequently, cells were cocultured with iron
(FeSO4 · 7H2O, 100 M) and/or alginate (0.3 %) as described
in Section 2.2. To create 59Fe iron media, a stock solution
of iron (FeSO4 · 7H2O (108.9 mg, 10 mM) and sodium ascor-
bate (396mg, 500mM)) into DIH2O (40mL) was spiked with
59FeCl3 to reach a radiation concentration of 10 000 counts
per minute per well. This stock was diluted into the media
to create the 100 M FeSO4 · 7H2O as detailed above. To the
apical chamber, FCS-free Minimum Essential Medium with
59Fe-spiked iron with or without alginate (2 mL) was added.
At 0.5, 4- and 24-h time points, samples were removed from
the apical chamber. After 24 h, media were removed, and the
cells were washed with Versene (0.2 g/L1 EDTA in PBS) and
lysed in RIPA buffer. Samples collected were assessed for
iron concentration using scintillation counting.
2.3 Western blotting
Cells were incubated in iron (FeSO4 · 7H2O, 100 M) and/or
alginate (0.3% w/v in DI H2O) or D-glucuronic acid (DGA,
0.3% w/v in DI H2O) supplemented growth media for 24 h
prior to lysis in RIPA buffer. Western blotting was per-
formed as previously described, with monoclonal antibodies
to ferritin (1:5000, Abcam, Rabbit AB69090), -actin (1:5000,
Abcam, Mouse AB8226), and transferrin receptor 1 (TfR1;
1:1000, Invitrogen, H68.4) [13]. All blots were subject to den-
sitometry analysis using ImageJ analyzing software.
2.4 In vivo 59Fe experiments
All in vivo experiments were carried out under Home Office
approved conditions and animal care and the regulation of
scientific procedures met the criteria laid down by the United
Kingdom Animals (Scientific Procedures) Act 1986. Male,
6-wk-old, CD1 mice (Charles Rivers, UK) in groups of four
to eight were used in 59Fe absorption experiments. All mice
were starved 12 h prior to gavage and post administration
mice were given access to water and food ad libitum.
A 59Fe-spiked iron gavage solution was prepared by dilu-
tion of a Fe(II) stock solution (FeSO4 · 7H2O, 20 mM in 0.1
MHCl) into HEPES, a physiological buffer devoid of divalent
metal cations (HEPES, 16 mM, pH 7.4, NaCl 125 mM) to a
concentration of 250 M Fe(II). Administration of alginate
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solutions (8% w/v in DI H2O, 100 L) to half of the mice
was performed immediately after gavage of the prepared
radio-labeled iron (100 L), whereas the other half received
an iron-only gavage and no alginate. All mice were housed
in metabolic chambers for 48 h prior to culling to allow the
collection of fecal samples. After 48 h, mice were culled and
dissected. Intestinal sections (duodenum, jejunum, ileum,
and colon) were flushed once with a sodium chloride solution
(ca. 15 mL, 0.15 M) and detection of iron concentrations
was performed within these intestinal sections as previously
reported [17]. Carcass counts per minute measurements
were performed on a whole-body animal counter (LIVE-1,
Technical Associates, Canoga Park, CA, USA).
2.5 Heat degradation and viscosity measurements
Aqueous Manucol DH aliquots (10 mL) were heated at
100C for set time points. All viscosity measurements were
performed at 25C and alginate concentrations that were
used were within the kinematic range of the viscometer
(usually from 0.1 to 1 mg/mL). Viscosities were measured
on a Cannon-Ubbelohde glass viscometer (Cannon instru-
ments), size 50, with a kinematic viscosity range of 0.8 to
4 mm2/s.
2.6 Analytical ultracentrifugation
Sedimentation velocity and sedimentation equilibriumexper-
iments were performed on a BeckmanOptima XL-I analytical
ultracentrifuge (AUC) equipped with Rayleigh Interference
Optics and a 30 mW laser wavelength ( = 675 nm) as previ-
ously reported [18].
2.7 AlgE1 plasmid extraction and enzyme
production
Agar blocks inoculated with JM 109 containing plasmid
pHH1 encoding alginate epimerase 1 (AlgE1) was kindly do-
nated fromHelgaErtesva˚g (NorwegianUniversity of Sciences
and Technology). AlgE1 productionwas performed according
to the previously published protocol [19].
2.8 Assessing for activity of AlgE1 and preparation
of epimerized LD
To screen the purified enzyme fractions for epimerization
activity, aqueous Manucol LD (0.1% w/v) in DI H2O was
prepared. Manucol LD solution (2 mL) was mixed with the
enzyme fractions (1 mL) and MOPS buffer (80 mM, 1 mL)
supplemented with CaCl2 · 2H2O (4 mM). The resultant mix-
ture was incubated at 37C for 2 h. To quench the epimeriza-
tion, EDTA (50 mM) was added and the subsequent mixtures
were extensively dialyzed against DI H2O at 4C. The resul-
tant solutions were used directly in the circular dichroism
(CD) spectrometer. CD measurements were recorded on a
Jasco J-810 CD spectropolarimeter using a 1 cm path length,
blackened, quartz cell. The selected active fraction was used
to prepare epimerizedManucol LD (EpLD) for cell culture ex-
periments. Aqueous Manucol LD (0.2% w/v) was mixed with
MOPS buffer (180mM) supplemented with CaCl2 · 2H2O (40
mM) and the active enzyme (20 mL). The resultant solution
was agitated at 37C for 24 h, before enzyme deactivation was
initiated with the addition of EDTA (0.5 M). The mixture was
then extensively dialyzed at 4C. The subsequent alginate
product was pH adjusted (pH 7.4) and concentrated in
vacuo.
2.9 High-resolution NMR
1H NMR spectra were acquired on a Bruker Avance III 600
MHz instrument equipped with a 5 mm TCI Cryoprobe. The
residual solvent resonance was further suppressed using a
NOESY presto pulse sequence. A total of 32 transients and
16 steady-state scans were acquired with 16 384 complex
data points. The spectral width was set to 7184 Hz and the
sample temperature to 340 K. The free induction decays
were multiplied with a 0.3 Hz broadening exponential
window function and zero filled to 32 768 real data points
prior to Fourier transformation. The spectra were then
manually phase and baseline corrected, using a spline
baseline correction. Signals for the anomeric protons of
the different alginate constituents were fitted to Lorentzian
lines. All data processing and analysis was performed using
the Matlab-based MetaboLab software package [20].
2.10 Statistical analysis
All experiments were performed at least in triplicate unless
otherwise stated. Data were processed using Microsoft ex-
cel and results are presented as means with standard errors
of the mean (±SEM). The single-factor analysis of variance
(ANOVA, Analysis ToolPak,Microsoft Corporation) was used
to determine significant differences between the means of
three or more independent (unrelated) groups. The unpaired
t-test was used to statistically compare mean values between
two unrelated datasets within a group. A level of significance
was set to p < 0.05 for both tests of significance.
3 Results
3.1 Manucol LD demonstrates iron chelation in vitro
To screen the iron-binding potential of the range of alginates
used in this study, RKO cells were challenged with iron
(100 M) in the presence or absence of sodium alginates
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Figure 1. (A) Ferritin protein expression in RKO cells cocultured with iron (Fe) ± sodium alginates (LD, DH, GHB, LFR, KEL, RF, and AFH) for
24 h. Data points represent mean fold change in protein expression normalized to -actin, relative to control. (B) Ferritin protein expression
in RKO cells cocultured with different iron concentrations (Fe) ± LD, DH, GHB, LFR, KEL, RF, and AFH for 24 h. Data points represent mean
fold change in protein expression normalized to -actin, relative to control. (C) Total iron concentrations in RKO cells cultured ± Manucol
LD for 24 h. (D) Transferrin receptor expression in RKO cells incubated with iron ± Manucol LD. Data points represent mean fold change in
protein expression, normalized to -actin, relative to control. Error bars denote ±SEM; *statistical significance p < 0.05 versus iron-only
control and n = 3.
(Manucol LD (LD), Manucol DH (DH), Manugel GHB
(GHB), LFR5/60 (LFR), KELTONE (KEL), PROTANAL
RF6650 (RF) and PROTSEA AFH (AFH), 0.3% w/v) for
24 h and cells were then subsequently assayed for ferritin
expression; a surrogate marker for cellular iron levels
(Fig. 1A). As expected, treating cells with iron-supplemented
media alone induced ferritin expression (p < 0.05). Only one
alginate (Manucol LD) was able to significantly decrease the
iron-induced ferritin response by 60% (p < 0.05). Similarly,
culture of RKO cells at lower concentrations of iron (1 and
10 M) in the presence or absence of alginates (LD, DH,
GHB, LFR, KEL, RF and AFH, 0.3 % w/v) demonstrated that
Manucol LD was the only alginate to significantly reduce
ferritin expression by 70, 88, and 68% at 1, 10, and 100 M
concentrations of iron, respectively, compared with the
iron-only control (p < 0.05, Fig. 1B). DH, GHB, and LFR
only inhibited ferritin expression at 10 M iron by 54, 47,
and 92%, respectively (p < 0.05, Supporting Information
Fig. 1). Manucol LD was the only alginate to demonstrate
bioactivity at all concentrations of iron.
In order to fully verify the iron chelation ability ofManucol
LD in vitro, RKO cells were challenged with iron (100 M)
with or without Manucol LD (0.3% w/v) for 24 h before being
assessed for direct intracellular iron concentrations (Fig. 1C)
and TfR1 expression (Fig. 1D). RKO cells treated with iron re-
sulted in cellular iron loading (ca. 50 nM total cellular iron);
the basal levels of iron within the control group were not
measureable by this assay. It was found that Manucol LD sig-
nificantly decreased cellular iron loading by 62% (p < 0.05)
(Fig. 1C). This was associated with a statistical increase in
TfR1 expression by approximately 50% (p < 0.05) compared
with iron alone, indicating that Manucol LD is binding the
supplemented iron present in the media hindering its intra-
cellular uptake (Fig. 1D).
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Figure 2. (A) Iron concentration in Caco-2 cells incubated with iron ± Manucol LD. (B) 59Fe concentrations at 0.5, 4, and 24 h in the apical
chamber following culture with iron ± Manucol LD. Error bars denote ±SEM; *statistical significance, p < 0.05 versus iron-only control.
3.2 Manucol LD demonstrates iron chelation in an
in vitro model of the intestinal lumen
Using radiolabeled iron-spiked cell culture media, Manucol
LD significantly decreased intracellular iron concentrations
by 70% (p < 0.05) within the Caco-2 monolayer compared
with the iron-only control (Fig. 2A). By assessing the levels
of iron within the apical chamber during the experiment, it
could be determined that iron was retained within this com-
partment (Fig. 2B). Co-incubation with Manucol LD at both 4
and 24 h inhibited cellular iron uptake by the Caco-2 cells by
60% (p< 0.05) compared with the iron-only control from the
apical compartment. These results validate the observation
that Manucol LD is binding iron in the media, thus prevent-
ing its cellular internalization.
3.3 Manucol LD demonstrates iron chelation within
the gastrointestinal tract in vivo
Administration of Manucol LD resulted in significantly de-
creased carcass iron concentrations by 71% (p < 0.005) com-
pared with an iron-only cohort (Fig. 3A). This equates to
only 13% of the total iron administered being absorbed when
Manucol LD was present compared to 46% when it was ab-
sent (Supporting Information Fig. 2). In addition, there was
a concomitant increase in fecal iron concentrations of 45%
(p < 0.05) in mice administered Manucol LD compared with
mice administered iron alone (Fig. 3B). To fully verify the
iron chelation potential of Manucol LD throughout the gas-
trointestinal tract, the stomach, duodenum, and colon were
assayed for iron concentration and it was found that in all
gastrointestinal tissues there were statistically decreased iron
concentrations when mice were administered Manucol LD
compared with iron alone (Fig. 3C). Specifically, a signifi-
cant decrease of 53, 60, and 52% (p < 0.05) in the stomach,
duodenum, and colon was found, respectively. Moreover, the
iron concentrations significantly increase from the stomach
to the duodenum to the colon (stomach → duodenum 73%
increase, stomach → colon 83 % increase (p < 0.05)). All
mice received the same concentration of 59Fe radioactive gav-
age (Fig. 3D).
3.4 Chemical characterization of alginates
To establish why Manucol LD demonstrated bioactivity and
the other alginates did not, chemical characterization of the
alginate series was performed. Both assessment of molecular
weight by AUC (Supporting Information Fig. 3) and G:M
composition byNMR (data not shown)was performed [21,22].
A summary of these results is described in Table 1. Manucol
LD was found to have a molecular weight distribution of 145
kDa.Manucol LDwas also found to have a G:M ratio of 38:62;
however, this composition was not unique to Manucol LD as
Manucol DH had a similar G:M ratio of 40:60.
3.5 Alginate iron chelation is molecular weight
dependent
Since Manucol DH and Manucol LD shared similar G:M
composition homology, yet Manucol DH was found to have
a higher molecular weight than Manucol LD (cf. 170 vs.
145 kDa), to determine if the difference in bioactivity was
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Figure 3. (A) Whole carcass (total absorbed iron across the gut) 59Fe counts per minute concentrations 48 h post administration with iron
± Manucol LD. (B) Fecal 59Fe counts per minute 48 h post administration with iron ± Manucol LD. (C) Stomach, duodenum, and colon 59Fe
CPM concentrations 48 h post administration of iron ± Manucol LD. (D) Total accountable 59Fe CPM concentrations for each experimental
group compared to the dose concentration of 59Fe administered. Error bars denote ±SEM; *,**statistical significance p < 0.05 and 0.005
versus iron-only control.
Table 1. Summary of AUC data to determine alginate molecular
weight (kDa) and NMR spectroscopy to determine algi-
nate G:M composition
Alginate MW (kDa) G:M
RF 230 ± 10 60:40
KEL 220 ± 15 46:54
GHB 180 ± 18 53:47
DH 170 ± 6 40:60
AFH 155 ± 5 29:71
LD 145 ± 5 38:62
LFR 74 ± 3 62:38
due to the molecular weight of Manucol DH, Manucol
DH was subject to heat degradation to produce smaller
molecular weight average alginate degrade products (ADPs)
as previously described [23]. The relative viscosity decreases
as expected with longer heating times, and the mean values
for intrinsic viscosity obtained can be calibrated against
heating time (Fig. 4A). The resultant ADPs (0.3% w/v)
were subsequently co-cultured in the presence or absence
of iron (100 M) in vitro for 24 h to examine their effects
on iron-induced ferritin expression (Fig. 4B). Coculturing
RKO cells with native Manucol DH does not demonstrate
any iron chelation effects as described previously (Fig. 1A).
Heat degradation of Manucol DH for 20 and 40 min and
subsequent coculture of these ADPs on RKO cells also
reveals no iron-binding ability. However, heat degradation
for 80 and 160 min statistically reduced iron-mediated
ferritin expression by approximately 50% (p < 0.05), but not
to the extent of Manucol LD (Fig. 4B). Further degradation
(250 min) resulted in a loss of this bioactivity. As a further
control, the effect of the monomeric acid unit on cellular iron
metabolism was assessed. DGA (0.3% w/v) was cocultured
alongside RKO cells in the presence or absence of iron
(100 M). There was no statistical reduction in iron-induced
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Figure 4. (A) Manucol DH relative viscosity (rel) decreases by heating at 100C with a plot of intrinsic viscosity against heating time. Error
bars denote ±SEM. (B) Ferritin protein expression in RKO cells incubated with iron ± Manucol DH heat degradation products for 24 h. Data
points represent mean fold change in protein expression, normalized to -actin, relative to control. Error bars denote ±SEM, *statistical
significance p < 0.05 versus iron-only control and n = 3. (C) 59Fe concentrations in RKO cells incubated with iron challenged ± DGA. Data
points represent mean fold change in protein expression, normalized to -actin, relative to control. Error bars denote ±SEM. (D) Ferritin
protein expression in RKO cells incubated with iron ± DGA. Data points represent mean fold change in protein expression, normalized to
-actin, relative to control. Error bars denote ±SEM. NS, no statistical significance.
ferritin expression or 59Fe levels when cells were cultured
alongside DGA compared with iron only (Fig. 4C and D).
3.6 Alginate iron chelation is composition
dependent
Manucol LD and Manucol DH have similar G:M chem-
ical compositions but this does not preclude differences
in GM sequence structure. To examine this, they were
both subject to high-resolution NMR to allow calculation of
their respective monad (G/M), diad (GM/GG/MM), or triad
(GMG/GGM/MGM/MMG) concentrations [24]. NMR spec-
tra for Manucol LD and Manucol DH were acquired and
analyzed using the correlations described and transformed
free-induction decays were fitted to Lorentzian curves to allow
calculation of the specific monads, diads, and triads (Fig. 5A
andB) according to a standard protocol [24]. Calculation of the
major differences between Manucol LD and Manucol DH re-
vealed that Manucol LD contained 12%more MM diads than
Manucol DH. Similarly, Manucol DH contained 8% more
GM diads than Manucol LD.
To interrogate the dependence on G:M composition
and sequence structure, an alginate epimerase enzyme
(AlgE1) was produced and utilized for the M→G conversion
of Manucol LD. Epimerization of native Manucol LD by
AlgE1 resulted in an approximate twofold increase in
guluronate residues on EpLD, resulting in a new G:M ratio
of 77:23; the highest G-unit concentration alginate out of
the series as assessed by CD spectroscopy (Fig. 5C). There
was also very little absorption present at  = 280 nm on the
UV-Vis, indicating negligible AlgE1 protein contaminant.
To examine the effects of epimerization of Manucol LD on
iron-induced ferritin expression, RKO cells were cocultured
in the presence or absence of Manucol LD or EpLD with or
without iron for 24 h before ferritin expression was examined
(Fig. 5D). Ferritin expression in RKO cells treated with iron
was significantly higher than that of control media only,
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Figure 5. Experimental (red) and simulated (blue) NMR spectra of alginate (A) Manucol DH and (B) Manucol LD for the region of protons
1 and 5 of M and glucuronic acid. (C) CD spectra and representative UV-Visible spectra of Manucol LD and EpLD. (D) Ferritin expression
in RKO cells incubated with iron ± Manucol LD and EpLD. Data points represent mean fold change in protein expression, normalized to
-actin, relative to control. Error bars denote ±SEM, *statistical significance p < 0.005 versus iron-only control and n = 3.
as expected. Manucol LD statistically diminished ferritin
expression by 57% compared with iron-only control (cf.
60% in previous studies, p < 0.005). EpLD did not reduce
ferritin expression compared with the iron-only control, and
expression was statistically increased by 63% compared with
Manucol LD treatment (p < 0.005, Fig. 5D).
4 Discussion
The detrimental effect of excess iron within the colon has
previously been reported [5, 6, 25, 26]. The ingestion of high
amounts of red and processed meats, foods that contain high
levels of iron, have also been implicated in gastrointestinal
disease [27, 28]. Exactly how iron is mediating disease pro-
gression within the large bowel is currently unknown. De-
spite this, in a range of conditions associated with iron ex-
cess, there is evidence that iron chelation is therapeutically
beneficial [29]. However, in the context of gastrointestinal dis-
ease it is specifically an excess of luminal ironwithin the large
bowel that is detrimental and the chelation of this pool of iron
presents itself as a potential therapeutic platform to improve
intestinal health.
In order to selectively chelate iron within the lumen of
the colon, the therapeutic compound must not be absorbable
such that it reaches the large bowel and binds excess iron.
Nondigestible fibers have been demonstrated to improve
gastrointestinal health [30], yet whether these effects are at-
tributed to their iron-binding properties is unknown. Sodium
alginates that are fibers found within the human diet have
previously been demonstrated to be both nonabsorbable and
bind iron [13, 14]. The possible range of alginate composi-
tions is huge due to the diversity in polymer length and G:M
chemical composition [31, 32]. How these compositional dif-
ferences affect iron-binding potential and subsequent in vitro
and in vivo cellular iron modulation is unknown, with previ-
ously published reports being inconsistent in their findings
[14, 33–35]. This inconsistency is likely due to the fact that
chemically different alginates were used throughout these
studies, and data presented in this study demonstrate the de-
pendence of iron chelation bioactivity on alginate chemical
composition.
A range of alginates with different molecular weights
and G:M compositions were primarily screened to assess
their in vitro iron chelation potential. This initial assessment
identified only one alginate that was able to modulate iron
metabolism in vitro. Manucol LD decreased ferritin expres-
sion by 60% (Fig. 1A and B), decreased total cellular iron
by 62% (Fig. 1C), restored TfR1 expression to control levels
(Fig. 1D), and decreased absorption of iron in Caco-2 cells by
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70% (Fig. 2A and B); this was the only alginate to have con-
sistent iron chelation properties (all statistically significant to
p < 0.05). In vivo, Manucol LD was able to suppress iron
absorption by 71% and increased the iron content found in
fecal samples by 45% (p< 0.05, Fig. 3). These two results are
pivotal in demonstrating the mechanism of iron binding by
Manucol LD within the gastrointestinal tract, where it can be
inferred that Manucol LD binds iron and keeps it chelated
until defecation. Where the iron is interacting with Manucol
LD within the gastrointestinal tract remains unclear; how-
ever, as alginates are insoluble in low-pH environments and
form insoluble capsules, it is likely that iron chelation would
not take place until Manucol LD reachedmore basic, distal re-
gions of the gut [36]. Interestingly, the concentrations of iron
within the mucosa of gastrointestinal tissues increase from
the small to the large bowel (stomach< duodenum< colon).
This is likely to be a consequence of either (i) more effective
iron transport across the brush border in the duodenum than
within the colon, (ii) the increased length of exposure to iron
in the digesta within the colon, or (iii) a combination of both.
This finding is supported by studies that have demonstrated
that the colon is able to import iron but there is a lack of reg-
ulated iron efflux [37]. Thus unsurprisingly, Manucol LD had
its greatest iron chelation effects within the colon, decreasing
iron absorption by 56% (p < 0.05).
Manucol LD has iron chelation effects both in vivo and
in vitro; however, what remains unclear is the redox state
and likely species of iron that alginate is chelating to within
these experimental conditions. Since sodium ascorbate was
includedwithin the growthmedia in cell culture experiments,
it is likely that the supplemented ferrous iron will remain in
the “free” ferrous form (“free” referring to its availability to
chelation by competing ligands), which would suggest that
Manucol LD is certainly binding to free ferrous iron. In ad-
dition previous reports have indicated that alginate will also
bind ferric iron [13]. It can be inferred that Manucol LD is
likely to have iron chelation ability toward ferrous and ferric
ions, yet this does not rule out the possibility that iron could
be forming nanoparticulate species within the gastrointesti-
nal tract [38], which alginates have also been documented
to stabilize [39]. If indeed iron in its “free” form is present
within the colon, then these data suggest that Manucol LD is
able to bind such a form of iron and possibly nanoparticulate
forms based on previously published reports [13]. However,
the species of iron present within the colon is currently un-
known and could be in its “free” state, bound to other dietary
or endogenous intestinal compounds or even as particulate
mineralized species [38, 40, 41].
To interrogate the chemical characteristics of alginate re-
quired for iron chelation and subsequent modulation of cel-
lular iron metabolism, Manucol LD and Manucol DH (the
latter an alginate with similar G:M composition but different
polymer length) were subject to structural modification by
alginate degradation (through heating) and M→G unit con-
version (by exposure to AlgE1). Determination of the heating
time required to reduce molecular weight by specific amount
allowed the calibration of intrinsic viscosity change against
heating time (Fig. 4A). Heat degradation of Manucol DH
at 100C decreased with heating time as previously reported
[42]. It was estimated that heating Manucol DH for approxi-
mately 3 h would provide an intrinsic viscosity value of 1200
mL/g, which would give a molecular weight similar to that of
Manucol LD (145 kDa). As such, heatingManucol DH for 180
min produced a shorter chain alginate (analogous to Manu-
col LD) that when cocultured in vitro with iron decreased
iron-induced ferritin expression by 50% (p < 0.05, Fig. 4B).
As a control, Manucol DH was heated for longer periods of
time (250 min) to produce shorter molecular weight prod-
ucts. Subsequent coculture of these ADPs resulted in dimin-
ished iron chelation ability to that observed with the 180-min
ADPs as ferritin levels were not significantly different to the
iron-only control. As a further control, RKO cells were co-
cultured with iron in the presence of DGA to examine if the
individual monomeric acid unit was able to modulate cellu-
lar iron metabolism; DGA also had no significant effects on
ferritin expression or intracellular 59Fe concentration. These
results demonstrate the importance of polymer length on
iron-binding ability, and it has recently been reported how
the polymeric nature of alginate orchestrates iron chelation
[13]. Thus, in summary an alginate molecular weight of ap-
proximately 145 kDa is required for maximal iron chelation
bioactivity.
It is plausible that Manucol LD has a tertiary and sec-
ondary structure that forms an iron-binding pocket or cavity;
this structure is formed by the specific MG sequence of the
alginate. The iron-binding site acts as a nucleation site for
iron deposition and such mechanisms have been previously
reported for other biopolymers [39]. If this were the case, then
alteration of theG:M ratio and thusGMsequence onManucol
LD would disrupt the formation of this binding site. Indeed,
data presented in this study have demonstrated this. Alginate
epimerase 1 was utilized to convert Manucol LD (G:M 38:62)
to EpLD (G:M 77:23). Subsequent coculture of EpLD in the
presence of iron did not reduce ferritin expression as demon-
strated for native Manucol LD. Such results demonstrate the
importance of a specific alginate G:M ratio and GM sequence
in iron chelation bioactivity. To fully confirm the uniqueness
of Manucol LD, high-resolution NMR spectroscopy showed
that Manucol DH and Manucol LD (two alginates with sim-
ilar G:M ratio) do indeed have different GM sequence ho-
mologies, where differences in MM and GM (or MG) diad
frequencies are most apparent.
In summary, data presented here identify a unique al-
ginate, with a specific chemical composition and polymeric
length that demonstrate optimal iron chelation properties
both in vitro and in vivo. These data not only explain why
inconsistencies have previously been reported on alginate
modulation of cellular iron metabolism but also detail the re-
quired chemical characteristics of an alginate for iron chela-
tion bioactivity. Importantly, if Manucol LD is to be used to
chelate excess colonic luminal iron, it will require formulat-
ing so as to ensure colonic delivery. Without employment
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of a colonic delivery platform, our data might predict that
chronic consumption of Manucol LD could lead to iron defi-
ciency, due to iron chelation within the small bowel. In the
context of modulating the intestinal microbiome, it is known
that iron is able to alter microbial colonization to a more
pro-inflammatory enterotype and it could be envisaged that
Manucol LD could suppress the colonization of these “non-
beneficial” bacteria (such asBacteroides) through the chelation
of luminal iron [11,43,44]. Further to this, alginates may have
prebiotic effects acting as a support scaffold for the coloniza-
tion of beneficial bacteria and as such further testing of these
pro- and prebiotic effects in man is required.
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